144 related articles for article (PubMed ID: 20459536)
1. Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas.
Mankey CC; McHugh JB; Thomas DG; Lucas DR
Histopathology; 2010 Feb; 56(3):364-71. PubMed ID: 20459536
[TBL] [Abstract][Full Text] [Related]
2. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
Fukunaga M
Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
[TBL] [Abstract][Full Text] [Related]
3. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas.
Itakura E; Yamamoto H; Oda Y; Tsuneyoshi M
J Surg Oncol; 2008 Jan; 97(1):74-81. PubMed ID: 18041747
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
7. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
Parsons A; Sheehan DJ; Sangueza OP
Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
[TBL] [Abstract][Full Text] [Related]
8. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
Tokuyama W; Mikami T; Masuzawa M; Okayasu I
Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
[TBL] [Abstract][Full Text] [Related]
9. Stewart-Treves syndrome angiosarcoma expresses phenotypes of both blood and lymphatic capillaries.
Stanczyk M; Gewartowska M; Swierkowski M; Grala B; Maruszynski M
Chin Med J (Engl); 2013 Jan; 126(2):231-7. PubMed ID: 23324269
[TBL] [Abstract][Full Text] [Related]
10. Histological differentiation, histogenesis and prognosis of cutaneous angiosarcoma.
Kamo R; Ishii M
Osaka City Med J; 2011 Jun; 57(1):31-44. PubMed ID: 22106765
[TBL] [Abstract][Full Text] [Related]
11. The use of novel lymphatic endothelial cell-specific immunohistochemical markers to differentiate cutaneous angiosarcomas in dogs.
Halsey CH; Worley DR; Curran K; Charles JB; Ehrhart EJ
Vet Comp Oncol; 2016 Sep; 14(3):236-44. PubMed ID: 24593773
[TBL] [Abstract][Full Text] [Related]
12. Lymphangiosarcoma in a cat.
Sugiyama A; Takeuchi T; Morita T; Okamura Y; Minami S; Tsuka T; Tabuchi T; Okamoto Y
J Comp Pathol; 2007; 137(2-3):174-8. PubMed ID: 17706243
[TBL] [Abstract][Full Text] [Related]
13. Lymphangiosarcoma of the scalp.
Mamelak AJ; Collie MR; Kroll R; Hanson ML; Harris HM
J Cutan Med Surg; 2014; 18(2):132-6. PubMed ID: 24636440
[TBL] [Abstract][Full Text] [Related]
14. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
[TBL] [Abstract][Full Text] [Related]
16. Pseudolymphomatous cutaneous angiosarcoma: a rare variant of cutaneous angiosarcoma readily mistaken for cutaneous lymphoma.
Requena L; Santonja C; Stutz N; Kaddu S; Weenig RH; Kutzner H; Menzel T; Cerroni L
Am J Dermatopathol; 2007 Aug; 29(4):342-50. PubMed ID: 17667166
[TBL] [Abstract][Full Text] [Related]
17. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases.
Neuhauser TS; Derringer GA; Thompson LD; Fanburg-Smith JC; Miettinen M; Saaristo A; Abbondanzo SL
Mod Pathol; 2000 Sep; 13(9):978-87. PubMed ID: 11007038
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS).
Masuzawa M; Masuzawa M; Hamada Y; Arakawa N; Mori M; Ishii M; Nishiyama S
Cancer Med; 2012 Aug; 1(1):39-46. PubMed ID: 23342252
[TBL] [Abstract][Full Text] [Related]
19. Distribution of lymphatic vessels in mouse thymus: immunofluorescence analysis.
Odaka C; Morisada T; Oike Y; Suda T
Cell Tissue Res; 2006 Jul; 325(1):13-22. PubMed ID: 16541287
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.
Jussila L; Valtola R; Partanen TA; Salven P; Heikkilä P; Matikainen MT; Renkonen R; Kaipainen A; Detmar M; Tschachler E; Alitalo R; Alitalo K
Cancer Res; 1998 Apr; 58(8):1599-604. PubMed ID: 9563467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
